Industries > Healthcare > New Product Market Entry

New Product Market Entry

We assist our industry clients in creating, communicating, and providing value to their target markets. We support them in evaluating, designing, and building a roadmap to follow, along with constructing the necessary support systems. This, in turn, aids in optimizing the new launch and dramatically enhancing their chances for marketing success, along with offering them credible content support during the new product entry strategy planning.

Blogs | Wearable Tech: A Promise to Revolutionize Healthcare

SGAs new product market entry strategy services cover the 5Ps of success Product, Place, Process, Price, and Promotion

SG Analytics (SGA) is recognized as one of the few healthcare market research consulting companies that has been helping start-ups and new players enter the global markets successfully before and after the COVID-19 pandemic.  Our new product market entry strategy services offer a 360° overview for our clients, which includes: 

  • Identifying and targeting the ideal customer – We assist our clients in identifying the most attractive markets with higher demand and lower competition for their products among all the segments. 

  • Measuring the competitive intelligence (CI) of peers to update the company website – Our CI team specializes in mapping the peers along with their marketing activities. Strong marketing content is provided for the new product and its therapeutic area. 

  • Marketing support – SGA’s marketing team collaborates with the client-side teams to design educational, email, and social media marketing programs and runs surveys with the right potential candidates to map and evaluate the success of the product launch. 

  • Peak sales forecast – SGA’s financial analysts assist the clients in understanding the opportunities in the near term and future by building peak sales forecasting models. 

  • Sales force effectiveness (SFE) – Our experts in the SFE team map the demand versus the availability of products and design the sales force per market. This aids in adding cost optimization, gaining a higher rate of success, and generating long-term revenue for the client. 

  • We specialize in medical device market entry strategy services in the GCC countries, the LATAM, and Asia Pacific regions, and have assisted German and US medical devices manufacturers with medical equipment entry strategies for niche clients and high-volume clients (such as patients with diabetes). 

New Product Market Entry Strategy


Industry Leaders

SGA thrives by its brand promise Life is Possible and is recognized as the trusted healthcare market research consulting company.

12+ Languages

Language capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (US/UK).

Data-Driven Insights

With our deep domain and business knowledge of the global healthcare value chain, along with our proven capabilities, we deliver data-driven, actionable, and monetizable insights.

End-To-End Solutioning

SGA has an in-house key opinion leader (KOL) capability of more than 700 across major and new markets, which assist us in leveraging credible competitive insights before our peers.

Who We Work With


Whitepaper Market Entry in 2023

White Papers

Market Entry in 2023: Why Must You Also Look at Markets Other Than the US and Japan?

Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...

SGA Whitepaper Blue Ocean Strategy

White Papers

The Blue Ocean Strategy in the Pharmaceutical Industry: What Is the Blue Ocean Strategy About?

Blue ocean refers to a new market that presents low competition, is less crowded, and is open to accommodate new innovations and marketing opportunities....

SGA Healthcare Whitepaper Healthcare Consulting & Analytics

White Papers

What Happens When You Invest in Healthcare Consulting and Analytics?

Healthcare providers who are struggling with high-volume complex data are feeling the need for assistance with data convergence and management. With...

We strongly believe in women power. Our research team consists of more females than males i.e., 55 % females, and consists of PhDs, M Pharms, D Pharms, Postgraduate in finance, Biotech postgraduates, and MBAs.

Our combined experience of pharmaceuticals, medical devices, life sciences, and med-tech ensures high quality, white labelled research coverage.